Built by skeptics.
For skeptics.
Nooganics started with a spreadsheet. We were three friends — a neuroscientist, a former supply-chain lead, and an ex-product manager — and every one of us had a stack of bottles in the kitchen cabinet, an AG1 subscription we kept forgetting to cancel, and a creeping suspicion we were being sold a story.
So we opened the source data. We pulled every ingredient in our cabinets, cross-referenced the label doses against the published trial doses, and the math was ugly. Most of what we were taking was underdosed by 50% or more. Some of it was propped up by asterisks that pointed to studies using double, triple, even ten times the dose on our shelves.
That spreadsheet became a formulation brief. The brief became four packs. And every decision since — the labeling standard, the single-supplier ashwagandha, the per-batch testing, the price we'd charge a friend — comes back to that one kitchen-cabinet moment. Build the brand you can't find.
We're launching in summer 2026 with founding-member pricing that won't return. If our thesis resonates — get on the list.